Your browser doesn't support javascript.
loading
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus.
Khurana, Ishant; Howard, Natasha J; Maxwell, Scott; Du Preez, Anelle; Kaipananickal, Harikrishnan; Breen, James; Buckberry, Sam; Okabe, Jun; Al-Hasani, Keith; Nakasatien, Soontaree; Himathongkam, Thep; Cooper, Mark E; Maple-Brown, Louise; Thewjitcharoen, Yotsapon; Brown, Alex; El-Osta, Assam.
Afiliação
  • Khurana I; Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Howard NJ; Wardliparingga Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia.
  • Maxwell S; Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Du Preez A; Wardliparingga Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Kaipananickal H; Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Breen J; National Centre for Indigenous Genomics, Australian National University, Canberra, ACT, Australia; Telethon Kids Institute, Perth, WA, Australia.
  • Buckberry S; National Centre for Indigenous Genomics, Australian National University, Canberra, ACT, Australia; Telethon Kids Institute, Perth, WA, Australia.
  • Okabe J; Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Al-Hasani K; Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Nakasatien S; Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand.
  • Himathongkam T; Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand.
  • Cooper ME; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia.
  • Maple-Brown L; Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia; Department of Endocrinology, Royal Darwin Hospital, Northern Territory, Australia.
  • Thewjitcharoen Y; Diabetes and Thyroid Center, Theptarin Hospital, Bangkok, Thailand.
  • Brown A; National Centre for Indigenous Genomics, Australian National University, Canberra, ACT, Australia; Telethon Kids Institute, Perth, WA, Australia. Electronic address: alex.brown@anu.edu.au.
  • El-Osta A; Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia; University College Copenhagen, Faculty of Health, Department of Technology, Biomedical Labora
Diabetes Res Clin Pract ; 204: 110918, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37748713
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Diabetes Res Clin Pract Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Diabetes Res Clin Pract Ano de publicação: 2023 Tipo de documento: Article